Clinical Trial Update: Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on using micafungin to prevent invasive fungal disease in children undergoing allogeneic hematopoietic stem cell transplantation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Fungal Infection

Drugs mentioned

• Micafungin (micafungin)

Snippet

Sponsor: Asan Medical Center | Conditions: Neutropenia, Hematopoietic Stem Cell Transplantation | Phase 4 | Status: UNKNOWN